Navigation Links
B. Braun Selects 1WorldSync Unique Device Identification and Product Information Solution
Date:7/29/2014

Lawrenceville, NJ (PRWEB) July 29, 2014

1WorldSync announces B. Braun Melsungen AG, one of the world’s leading healthcare suppliers will utilize the Global Data Synchronization Network™ (GDSN®) standard and leverage 1WorldSync’s product information network to share product information with the U.S. Food and Drug Administration (FDA) and other trading partners across their global supply chain. Holger Clobes, Head of Global eCommerce & Auto ID at B. Braun: "B. Braun serves customers in 61 countries, among others with items for anesthesia, intensive medicine, cardiology, extracorporeal blood treatment and surgery. In order to provide our customers with reliable and relevant product information in accordance with the Unique Device Identification (UDI) regulations, we began in June 2014 to assess the 1WorldSync Global Data Synchronization Network (GDSN®) certified data pool."

The engagement with 1WorldSync allows B. Braun to efficiently distribute product information over a single channel, to meet the increasing demands from trading partners and to support the UDI regulation passed by the FDA: Holger Clobes stated, "With the 1WorldSync GDSN-certified data pool we can provide our customers, such as hospitals and medical buying groups comprehensive, reliable and trusted product information over a single channel at any time."

In implementing 1WorldSync's healthcare solution, B. Braun is now well prepared for the deadline set by the FDA to meet UDI regulation requirements. Volker Zeinar, Global Coordinator Auto-ID Affairs: "Every medical device registered in the U.S. must have its own identification number, called the Unique Device Identifier. In addition, preset medical device descriptive product information is required to be submitted into the FDA UDI database (GUDID) in an electronic predetermined format by the FDA (HL7 SPL). By using the GDSN-based solutions offered by 1World
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. The NAPW Announces June Braunlich, Founder and Owner, Nutrition SOULutions, 2013/2014 Professional Woman of the Year
2. B. Braun Will Sponsor Practice Greenhealth DEHP-Free Award
3. Eyefinity Selects Updox for Direct Messaging and Patient Portal
4. Magnolia Regional Health Center Selects Axiom EPM Solution Suite to Enhance Financial Management Capabilities, Support Strategic Business Planning
5. DARPA selects Lawrence Livermore to develop worlds first neural device to restore memory
6. Cooper Consulting Partners Selects Launch Agency to Brand New Company
7. Newman Regional Health Selects New Chief Executive Officer
8. UF Health Shands Center Selects BESLER Consulting’s Transfer DRG Revenue Recovery Service
9. HM Insurance Group Selects Array Health for Its Online Marketplace for Supplemental Insurance Products
10. NuScale Power Selects Synergy Business Solutions to Implement Microsoft Dynamics SL Project-accounting and Financial Software
11. University of Kentucky Health System Selects lifeIMAGE for Medical Image Sharing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015 The human augmentation market is ... market. The wearable augmentation sector is predicted to outpace ... the upcoming years. , The eye-wear sector dominates ... big number of new products launches in the region. ... technological advancements as well as the rising demand for ...
(Date:3/3/2015)... 2015 Daylight Savings Time may lead to ... has tips for parents. , Parents and their children may ... a.m. when they set their clocks forward one hour for ... day -- one hour earlier -- you will have already ... start thinking about “sleep hygiene” for their kids and teens ...
(Date:3/3/2015)... Sunday, March 1, through Saturday, March 7, is National ... every region of the country is at risk for some ... is sharing the following tips from the Centers for ... safe in the event of severe weather: , Winter storms, ... to prevent loss of body heat. Wear warm, loose-fitting, lightweight ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 -- vRad ( Virtual Radiologic ... today announced that Arlene Sussman, MD, a highly regarded ... live webinar to explore how telemedicine best practices allow ... services for women virtually anywhere. Click here ... Line” on March 4, 2015 at 1:00 pm CT. ...
(Date:3/3/2015)... CA (PRWEB) March 03, 2015 ... and collaboration, announces Mirroring360 is now available for Epson® ... download from the Moverio Apps Market , iPod, ... mobile device experience to the Epson Moverio smart glasses ... usage models. , The Epson smart glasses ...
Breaking Medicine News(10 mins):Health News:Human Augmentation Market to Pose 43.5% CAGR Through 2020, States MarketsandMarkets in its New Research Study Now Available at MarketPublishers.com 2Health News:Don’t Let Daylight Savings Disrupt Your Child’s Sleep 2Health News:Amica Insurance Has Tips for National Severe Weather Preparedness Week 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 3Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 4Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 2Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 3
... NEW YORK (Oct. 17, 2007) -- Two reports from ... light on male infertility. A first report shows that ... varicose veins in the scrotum -- also results in ... researchers demonstrate that once a common, simple surgery is ...
... Sessions relieve pain and help improve daily function, researchers ... stretching and aerobic workouts in warm water may help ... knee or hip osteoarthritis. , That finding was offered ... 800 patients. , In the studies, participants did aquatic ...
... into treatment, cure for,devastating lung disease, WASHINGTON, ... announced the passage of important legislation,that recognizes the ... fibrosis (IPF), a deadly lung disease with no ... diseases which claims 40,000 lives a,year, the same ...
... Highlights to Include New Research on HIV Screening, ... Bullying, WASHINGTON, Oct. 17 More than ... Nov. 3-7 to address the,nation,s top public health ... Annual Meeting., The conference will feature leading ...
... More Space in the Future to Keep Up ... Technologies,Inc. (Pink Sheets: RBRM), an emerging medical device ... Phillips, Ph.D., today,announced it is increasing its manufacturing ... medical devices and products. The company recently,contracted construction ...
... Suit Against Medtronic Inc., Medtronic Puerto Rico, Inc., and Medtronic Puerto Rico Operations ... Lead Used with a Medtronic Implantable ... Defibrillator, Class Action ... Implanted with Leads Manufactured by Medtronic, Inc., NEW YORK, Oct. 17 ...
Cached Medicine News:Health News:The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell 2Health News:Water Workouts Work for Arthritis Patients 2Health News:Resolution Recognizing Pulmonary Fibrosis Challenges Overwhelmingly Passes House 2Health News:Resolution Recognizing Pulmonary Fibrosis Challenges Overwhelmingly Passes House 3Health News:Resolution Recognizing Pulmonary Fibrosis Challenges Overwhelmingly Passes House 4Health News:Thousands of Public Health Experts to Address Leading Issues at APHA Annual Meeting, Nov. 3-7 2Health News:ReBuilder Medical Technologies, Inc. Increases Manufacturing Space to Meet Demand 2Health News:ReBuilder Medical Technologies, Inc. Increases Manufacturing Space to Meet Demand 3Health News:Parker Waichman Alonso LLP, Along with Smith & Nevares, Salas & Co. and Becnel 2Health News:Parker Waichman Alonso LLP, Along with Smith & Nevares, Salas & Co. and Becnel 3
(Date:3/3/2015)... 2015  AT&T 1 and Royal Philips ...  is the connectivity provider for Philips GoSafe, Philips, leading ... provide peace of mind to seniors at home or ... active lives with the confidence that they can get ... network 2 helps power GoSafe and connects seniors ...
(Date:3/3/2015)... 2015   VWR  (NASDAQ:  VWR), a leading, ... announced today the expansion of its distribution agreement ... allows VWR increased access to NEB,s growing product ... and Puerto Rico.  In addition, customers will now ... platform, sales organization, and VWRCATALYST, our onsite services ...
(Date:3/3/2015)... , March 3, 2015  The eleventh annual Tucson ... of the world,s top research scientists, academics, oncologists and ... theories and learn about new outcomes in patient treatments ... Each year Ventana Medical Systems, Inc. ... sponsors the Tucson Symposium at the Hilton El Conquistador ...
Breaking Medicine Technology:AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 2AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 3AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 4VWR Announces Expansion of Distribution Agreement with New England Biolabs 2Global scientific collaborators to explore latest pathology and oncology advancements at Tucson Symposium 2
... Data presented at the 2008 iSBTc Annual Meeting -, ... 11:00 a.m. ET to discuss,results -, BRANFORD, Conn., ... today preliminary data from an ongoing Phase II,trial of ... of patients with unresectable Stage III or Stage IV ...
... at AASLD annual meeting, Pivotal Phase III ... failed prior treatment, SAN FRANCISCO, Nov. 1 ... that a planned interim analysis of a,Phase II ... C,protease inhibitor, in combination with peginterferon and ribavirin,markedly ...
Cached Medicine Technology:CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 2CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 3CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 4CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 5CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 6CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 7Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 2Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 3Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 4Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 5Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 6Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 7Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 8Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 9Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 10
Modified Freer periosteal elevator, #163, strong curve, 21 cm....
Williger periosteal elevator, 6 1/4", sharp, 5 mm wide....
Dolwick-Reich Condyle periosteal elevator, 17.5 cm, 7"....
Seldin periosteal elevator #23, flat handle, 19.5 cm, 7-3/4"....
Medicine Products: